{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:14:24Z","timestamp":1778591664429,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010559","name":"Children's Hospital of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK78755"],"award-info":[{"award-number":["R01 DK78755"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ymgme.2022.106982","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T22:29:43Z","timestamp":1671748183000},"page":"106982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model"],"prefix":"10.1016","volume":"138","author":[{"given":"Xue-Jun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AI-Walid","family":"Mohsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Mihalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keaton","family":"Solo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermal","family":"Aliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakuntala","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Kochersperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clinton","family":"Van\u2019t Land","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Karunanidhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summar","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Guadagnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma H.","family":"Giangrande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo G.V.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ymgme.2022.106982_bb0005","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1172\/JCI117947","article-title":"Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients","volume":"95","author":"Aoyama","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ymgme.2022.106982_bb0010","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41436-020-01070-0","article-title":"Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders","volume":"23","author":"Marsden","year":"2021","journal-title":"Genet. Med."},{"issue":"7 Suppl","key":"10.1016\/j.ymgme.2022.106982_bb0015","article-title":"Long-chain fatty acid oxidation disorders and current management strategies","volume":"26","author":"Vockley","year":"2020","journal-title":"Am. J. Manag. Care"},{"issue":"5","key":"10.1016\/j.ymgme.2022.106982_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10545-012-9542-6","article-title":"Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients","volume":"36","author":"Baruteau","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2022.106982_bb0025","article-title":"Acylcarnitine analysis by tandem mass spectrometry","volume":"Chapter 17","author":"Smith","year":"2010","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2022.106982_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jimd.12313","article-title":"Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: results from an open-label, long-term extension study","volume":"44","author":"Vockley","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2022.106982_bb0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10545-010-9090-x","article-title":"Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2022.106982_bb0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2016.05.007","article-title":"Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database","volume":"118","author":"Pena","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2022.106982_bb0045","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.celrep.2017.11.081","article-title":"Systemic messenger RNA therapy as a treatment for Methylmalonic Acidemia","volume":"21","author":"An","year":"2017","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.ymgme.2022.106982_bb0050","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1089\/hum.2019.090","article-title":"A new era for rare genetic diseases: messenger RNA therapy","volume":"30","author":"Martini","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.ymgme.2022.106982_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ajhg.2019.02.003","article-title":"Systemic mRNA therapy for the treatment of Fabry disease: preclinical studies in wild-type mice, Fabry mouse model, and wild-type non-human Primates","volume":"104","author":"Zhu","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106982_bb0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ymgme.2022.106982_bb0065","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.1038\/ncomms14630","article-title":"Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge","volume":"8","author":"Pardi","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ymgme.2022.106982_bb0070","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymgme.2022.106982_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.09.006","article-title":"Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo","volume":"109","author":"Kauffman","year":"2016","journal-title":"Biomaterials."},{"issue":"10","key":"10.1016\/j.ymgme.2022.106982_bb0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.ymgme.2022.106982_bb0085","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.ymgme.2022.106982_bb0090","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/hmg\/10.19.2069","article-title":"Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse","volume":"10","author":"Cox","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2022.106982_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10545-010-9121-7","article-title":"Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2022.106982_bb0100","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/hmg\/ddy403","article-title":"Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers","volume":"28","author":"Seminotti","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2022.106982_bb0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/519219","article-title":"A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency","volume":"81","author":"He","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2022.106982_bb0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ymgme.2010.12.005","article-title":"Identification and characterization of new long chain acyl-CoA dehydrogenases","volume":"102","author":"He","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2022.106982_bb0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.RES.0000088786.19197.E4","article-title":"Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice","volume":"93","author":"Exil","year":"2003","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ymgme.2022.106982_bb0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2362.2004.01308.x","article-title":"Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress","volume":"34","author":"Spiekerkoetter","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.ymgme.2022.106982_bb0125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/mt.2012.39","article-title":"Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy","volume":"20","author":"Keeler","year":"2012","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2022.106982_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ymgme.2004.09.006","article-title":"Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation","volume":"85","author":"Schuler","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2022.106982_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1304","article-title":"Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD)","volume":"10","author":"Vallejo","year":"2021","journal-title":"Clin. Transl. Immunol."},{"issue":"39","key":"10.1016\/j.ymgme.2022.106982_bb0140","doi-asserted-by":"crossref","first-page":"29834","DOI":"10.1074\/jbc.M110.139493","article-title":"Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.ymgme.2022.106982_bb0145","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.1074\/jbc.RA119.008680","article-title":"Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex","volume":"294","author":"Wang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2022.106982_bb0150","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150240","article-title":"Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies","volume":"36","author":"Wajner","year":"2015","journal-title":"Biosci. Rep."},{"issue":"8","key":"10.1016\/j.ymgme.2022.106982_bb0155","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/febs.14419","article-title":"Metabolite accumulation in VLCAD deficiency markedly disrupts mitochondrial bioenergetics and ca(2+) homeostasis in the heart","volume":"285","author":"Cecatto","year":"2018","journal-title":"FEBS J."},{"issue":"6628","key":"10.1016\/j.ymgme.2022.106982_bb0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/387090a0","article-title":"Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese","volume":"387","author":"Enerback","year":"1997","journal-title":"Nature."},{"issue":"7285","key":"10.1016\/j.ymgme.2022.106982_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.ymgme.2022.106982_bb0170","doi-asserted-by":"crossref","first-page":"H1289","DOI":"10.1152\/ajpheart.00811.2005","article-title":"Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase","volume":"290","author":"Exil","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.ymgme.2022.106982_bb0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1203\/PDR.0b013e31816ff6f0","article-title":"Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine","volume":"63","author":"Primassin","year":"2008","journal-title":"Pediatr. Res."},{"issue":"22","key":"10.1016\/j.ymgme.2022.106982_bb0180","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.100.22.2248","article-title":"Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children","volume":"100","author":"Bonnet","year":"1999","journal-title":"Circulation."},{"issue":"23","key":"10.1016\/j.ymgme.2022.106982_bb0185","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1111\/j.1742-4658.2006.05523.x","article-title":"Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects. Implications for a mechanism linking obesity and type 2 diabetes","volume":"273","author":"Ciapaite","year":"2006","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.ymgme.2022.106982_bb0190","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/cells10051239","article-title":"Different lipid signature in fibroblasts of long-chain fatty acid oxidation disorders","volume":"10","author":"Alatibi","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.ymgme.2022.106982_bb0195","article-title":"Physiological perspectives on the use of Triheptanoin as Anaplerotic therapy for long chain fatty acid oxidation disorders","volume":"11","author":"Sklirou","year":"2020","journal-title":"Front. Genet."},{"issue":"25","key":"10.1016\/j.ymgme.2022.106982_bb0200","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJM200006223422503","article-title":"Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue","volume":"342","author":"Hoeper","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2022.106982_bb0205","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2019-318269","article-title":"Messenger RNA therapy for rare genetic metabolic diseases","volume":"68","author":"Berraondo","year":"2019","journal-title":"Gut."},{"key":"10.1016\/j.ymgme.2022.106982_bb0210","article-title":"Preparation, culture, and immortalization of mouse embryonic fibroblasts","volume":"Chapter 28","author":"Xu","year":"2005","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.106982_bb0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-59745-019-5_13","article-title":"Isolation and culture of adult mouse hepatocytes","volume":"633","author":"Li","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.ymgme.2022.106982_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10616-011-9407-0","article-title":"A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development","volume":"64","author":"Severgnini","year":"2012","journal-title":"Cytotechnology."},{"issue":"26","key":"10.1016\/j.ymgme.2022.106982_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process on innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.ymgme.2022.106982_bb0230","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human Primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2022.106982_bb0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0076-6879(00)24236-5","article-title":"Mammalian branched-chain acyl-CoA dehydrogenases: molecular cloning and characterization of recombinant enzymes","volume":"324","author":"Vockley","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgme.2022.106982_bb0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbrep.2016.08.014","article-title":"Fasting induces prominent proteomic changes in liver in very long chain acyl-CoA dehydrogenase deficient mice","volume":"8","author":"Wang","year":"2016","journal-title":"Biochem. Biophys. Reports."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.106982_bb0245","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ymgme.2021.09.002","article-title":"Development and characterization of a mouse model for Acad9 deficiency","volume":"134","author":"Sinsheimer","year":"2021","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222004607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222004607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:48:34Z","timestamp":1778590114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222004607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1096719222004607"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.106982","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.106982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106982"}}